6.94
price down icon2.80%   -0.20
pre-market  Vorhandelsmarkt:  6.91   -0.03   -0.43%
loading
Schlusskurs vom Vortag:
$7.14
Offen:
$7
24-Stunden-Volumen:
2.38M
Relative Volume:
1.40
Marktkapitalisierung:
$1.20B
Einnahmen:
$25.55M
Nettoeinkommen (Verlust:
$-341.97M
KGV:
-2.4786
EPS:
-2.8
Netto-Cashflow:
$-304.44M
1W Leistung:
-5.96%
1M Leistung:
+26.64%
6M Leistung:
+113.54%
1J Leistung:
+18.84%
1-Tages-Spanne:
Value
$6.64
$7.25
1-Wochen-Bereich:
Value
$6.64
$7.64
52-Wochen-Spanne:
Value
$1.775
$7.64

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name
Firmenname
Relay Therapeutics Inc
Name
Telefon
617-370-8837
Name
Adresse
60 HAMPSHIRE STREET, CAMBRIDGE
Name
Mitarbeiter
197
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-21
Name
Neueste SEC-Einreichungen
Name
RLAY's Discussions on Twitter

Vergleichen Sie RLAY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RLAY
Relay Therapeutics Inc
6.94 1.23B 25.55M -341.97M -304.44M -2.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-04 Fortgesetzt Guggenheim Buy
2025-04-17 Eingeleitet Wells Fargo Equal Weight
2024-09-10 Fortgesetzt Goldman Buy
2024-09-10 Hochstufung Jefferies Hold → Buy
2024-09-10 Herabstufung Oppenheimer Outperform → Perform
2024-05-10 Hochstufung Barclays Equal Weight → Overweight
2023-04-20 Hochstufung Jefferies Underperform → Hold
2023-04-19 Hochstufung Raymond James Outperform → Strong Buy
2023-04-13 Eingeleitet Raymond James Outperform
2023-02-03 Eingeleitet Oppenheimer Outperform
2022-09-30 Eingeleitet Barclays Equal Weight
2022-09-02 Eingeleitet Stifel Buy
2022-06-06 Eingeleitet Jefferies Underperform
2022-02-01 Eingeleitet Berenberg Buy
2021-07-21 Eingeleitet BofA Securities Buy
2020-12-15 Bestätigt H.C. Wainwright Buy
2020-12-08 Eingeleitet JMP Securities Mkt Outperform
2020-11-05 Eingeleitet H.C. Wainwright Buy
2020-08-10 Eingeleitet Cowen Outperform
2020-08-10 Eingeleitet Goldman Buy
2020-08-10 Eingeleitet Guggenheim Buy
2020-08-10 Eingeleitet JP Morgan Neutral
Alle ansehen

Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten

pulisher
02:24 AM

How Relay Therapeutics Inc. stock compares to growth peers2025 Macro Impact & Daily Volume Surge Signals - newser.com

02:24 AM
pulisher
Nov 03, 2025

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November - Investing News Network

Nov 03, 2025
pulisher
Nov 03, 2025

Relay Therapeutics (NASDAQ: RLAY) to join Guggenheim, Jefferies chats on Nov. 10 & 19 - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Why hedge funds are buying Relay Therapeutics Inc. stockJuly 2025 Technicals & AI Driven Price Forecasts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 09:01:58 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Does Relay Therapeutics Inc. show high probability of reboundJuly 2025 Analyst Calls & Safe Capital Growth Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Has Relay Therapeutics Inc. found a price floorShort Setup & Capital Efficient Trade Techniques - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 06:18:27 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What machine learning models say about Relay Therapeutics Inc.Quarterly Investment Review & Weekly Breakout Stock Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Relay Therapeutics Inc. stock a top momentum play2025 Key Highlights & Detailed Earnings Play Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 01:59:20 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Backtesting results for Relay Therapeutics Inc. trading strategiesJuly 2025 Outlook & Long-Term Investment Growth Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How to forecast Relay Therapeutics Inc. trends using time seriesPortfolio Risk Summary & Low Drawdown Trading Techniques - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Building trade automation scripts for Relay Therapeutics Inc.2025 Key Lessons & Daily Technical Forecast Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How to use a screener to detect Relay Therapeutics Inc. breakouts2025 Stock Rankings & Weekly Watchlist of Top Performers - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Using Ichimoku Cloud for Relay Therapeutics Inc. technicalsMarket Sentiment Report & Daily Growth Stock Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Published on: 2025-11-02 22:47:47 - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Why retail investors favor Relay Therapeutics Inc. stockJuly 2025 Sentiment & Entry Point Confirmation Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Regression analysis insights on Relay Therapeutics Inc. performanceShare Buyback & Consistent Return Strategy Ideas - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Relay Therapeutics Inc.’s volatility index tracking explained2025 Breakouts & Breakdowns & Consistent Income Trade Ideas - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Key metrics from Relay Therapeutics Inc.’s quarterly dataGap Up & Verified Entry Point Signals - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Analyzing recovery setups for Relay Therapeutics Inc. investorsJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Relay Therapeutics (NASDAQ:RLAY) Insider Donald Bergstrom Sells 30,897 Shares - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Peter Rahmer Sells 21,394 Shares of Relay Therapeutics (NASDAQ:RLAY) Stock - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Relay Therapeutics (NASDAQ:RLAY) Insider Peter Rahmer Sells 19,135 Shares - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Insider Selling: Relay Therapeutics (NASDAQ:RLAY) CFO Sells 21,664 Shares of Stock - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

What drives Relay Therapeutics Inc stock priceValue Traps to Avoid & Join 100,000+ Investors Already Learning - earlytimes.in

Oct 31, 2025
pulisher
Oct 30, 2025

Relay Therapeutics Reaches New 52-Week High of $7.64 - Markets Mojo

Oct 30, 2025
pulisher
Oct 30, 2025

Relay Therapeutics president sells $225k in stock By Investing.com - Investing.com Canada

Oct 30, 2025

Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):